The neuron-specific isoform of glycogen synthase kinase-3β is required for axon growth

Journal of Neurochemistry

Volumn 113, Issue 1, 2010, Pages 117-130

  Castaño, Zafira ^a   Gordon Weeks, Phillip R ^b   Kypta, Robert M ^a,c  

^a CIC BIOGUNE   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Axin; Axon growth; Glycogen synthase kinase 3; SH SY5Y neuroblastoma cell line; Tau phosphorylation

Indexed keywords

AXIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; ISOENZYME; RETINOIC ACID; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN CELL; CONTROLLED STUDY; DRUG TARGETING; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE SILENCING; HUMAN; HUMAN CELL; NERVE CELL; NERVE FIBER GROWTH; NEURITE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; AXONS; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; CHAPERONIN 60; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; NEURITES; NEUROBLASTOMA; NEURONS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TAU PROTEINS; TRANSFECTION; TUBULIN;

RATTUS;

EID: 77749243065     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06581.x     Document Type: Article

References (50)

1. Abraha A., Ghoshal N., Gamblin T. C., Cryns V., Berry R. W., Kuret J. Binder L. I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113 (Pt 21 3737 3745.
2. Asuni A. A., Hooper C., Reynolds C. H., Lovestone S., Anderton B. H. Killick R. (2006) GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 24, 3387 3392.
3. Bain J., Plater L., Elliott M., Shpiro N., Hastie C. J., McLauchlan H., Klevernic I., Arthur J. S., Alessi D. R. Cohen P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297 315.
4. Beurel E. Jope R. S. (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 79, 173 189.
5. Boonen R. A., van Tijn P. Zivkovic D. (2009) Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Res. Rev. 8, 71 82.
6. Castano Z. Kypta R. M. (2008) Housekeeping proteins: limitations as references during neuronal differentiation. The Open Neuroscience Journal 2, 36 40.
7. Cohen N., Betts D. R., Rechavi G., Amariglio N. Trakhtenbrot L. (2003) Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line. Cancer Genet. Cytogenet. 143, 80 84.
8. Conde C. Caceres A. (2009) Microtubule assembly, organization and dynamics in axons and dendrites. Nat. Rev. Neurosci. 10, 319 332.
9. Dajani R., Fraser E., Roe S. M., Yeo M., Good V. M., Thompson V., Dale T. C. Pearl L. H. (2003) Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J. 22, 494 501.
10. Dill J., Wang H., Zhou F. Li S. (2008) Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 28, 8914 8928.
11. Droucheau E., Primot A., Thomas V. et al. (2004) Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors. Biochim. Biophys. Acta 1697, 181 196.
12. Frame S. Cohen P. (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1 16.
13. Garrido J. J., Simon D., Varea O. Wandosell F. (2007) GSK3 alpha and GSK3 beta are necessary for axon formation. FEBS Lett. 581, 1579 1586.
14. Goold R. G. Gordon-Weeks P. R. (2001) Microtubule-associated protein 1B phosphorylation by glycogen synthase kinase 3beta is induced during PC12 cell differentiation. J. Cell Sci. 114, 4273 4284.
15. Goold R. G. Gordon-Weeks P. R. (2004) Glycogen synthase kinase 3beta and the regulation of axon growth. Biochem. Soc. Trans. 32, 809 811.
16. Goold R. G., Owen R. Gordon-Weeks P. R. (1999) Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J. Cell Sci. 112 (Pt 19 3373 3384.
17. Grimes C. A. Jope R. S. (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391 426.
18. Hanger D. P., Anderton B. H. Noble W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112 119.
19. Hedgepeth C. M., Deardorff M. A., Rankin K. Klein P. S. (1999) Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin. Mol. Cell. Biol. 19, 7147 7157.
20. Huang H. He X. (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol. 20, 119 125.
21. Ishitani T., Ishitani S., Matsumoto K. Itoh M. (2009) Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin. J. Neurochem. 111, 1104 1118.
22. Johnson G. V. Stoothoff W. H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117, 5721 5729.
23. Kim W. Y., Zhou F. Q., Zhou J., Yokota Y., Wang Y. M., Yoshimura T., Kaibuchi K., Woodgett J. R., Anton E. S. Snider W. D. (2006) Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron 52, 981 996.
24. Kwok J. B., Hallupp M., Loy C. T., Chan D. K., Woo J., Mellick G. D., Buchanan D. D., Silburn P. A., Halliday G. M. Schofield P. R. (2005) GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann. Neurol. 58, 829 839.
25. Kwok J. B., Loy C. T., Hamilton G. et al. (2008) Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease. Ann. Neurol. 64, 446 454.
26. Kypta R. M., Su H. Reichardt L. F. (1996) Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J. Cell Biol. 134, 1519 1529.
27. Lee E., Salic A., Kruger R., Heinrich R. Kirschner M. W. (2003) The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 1, E10.
28. Li R. (2005) Neuronal polarity: until GSK-3 do us part. Curr. Biol. 15, R198 R200.
29. Lucas F. R., Goold R. G., Gordon-Weeks P. R. Salinas P. C. (1998) Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J. Cell Sci. 111 (Pt 10 1351 1361.
30. MacDonald B. T., Tamai K. He X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9 26.
31. Mazor M., Kawano Y., Zhu H., Waxman J. Kypta R. M. (2004) Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene 23, 7882 7892.
32. Mukai F., Ishiguro K., Sano Y. Fujita S. C. (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J. Neurochem. 81, 1073 1083.
33. Ng S. S., Mahmoudi T., Danenberg E., Bejaoui I., de Lau W., Korswagen H. C., Schutte M. Clevers H. (2009) Phosphatidylinositol 3-kinase (PI3K) signaling does not activate the Wnt cascade. J. Biol. Chem. 284, 35308 35313.
34. Orme M. H., Giannini A. L., Vivanco M. D. Kypta R. M. (2003) Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells. Mol. Cell. Neurosci. 24, 673 686.
35. Owen R. Gordon-Weeks P. R. (2003) Inhibition of glycogen synthase kinase 3beta in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones. Mol. Cell. Neurosci. 23, 626 637.
36. Pahlman S., Mamaeva S., Meyerson G., Mattsson M. E., Bjelfman C., Ortoft E. Hammerling U. (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl. 592, 25 37.
37. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z. A., Wang Y. T. Collingridge G. L. (2008) The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 153 (Suppl. 1 S428 S437.
38. Primot A., Baratte B., Gompel M., Borgne A., Liabeuf S., Romette J. L., Jho E. H., Costantini F. Meijer L. (2000) Purification of GSK-3 by affinity chromatography on immobilized axin. Protein Expr. Purif. 20, 394 404.
39. Scali C., Caraci F., Gianfriddo M. et al. (2006) Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol. Dis. 24, 254 265.
40. Schaffer B., Wiedau-Pazos M. Geschwind D. H. (2003) Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302, 73 81.
41. Stoothoff W. H., Bailey C. D., Mi K., Lin S. C. Johnson G. V. (2002) Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta. J. Neurochem. 83, 904 913.
42. Takahashi M., Yasutake K. Tomizawa K. (1999) Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. J. Neurochem. 73, 2073 2083.
43. Tanaka T., Iqbal K., Trenkner E., Liu D. J. Grundke-Iqbal I. (1995) Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett. 360, 5 9.
44. Trivedi N., Marsh P., Goold R. G., Wood-Kaczmar A. Gordon-Weeks P. R. (2005) Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons. J. Cell Sci. 118, 993 1005.
45. Wagner U., Brownlees J., Irving N. G., Lucas F. R., Salinas P. C. Miller C. C. (1997) Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells. FEBS Lett. 411, 369 372.
46. Wood-Kaczmar A., Kraus M., Ishiguro K., Philpott K. L. Gordon-Weeks P. R. (2009) An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones. Mol. Cell. Neurosci. 42, 184 194.
47. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A. Kaibuchi K. (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137 149. (Pubitemid 40094609)
48. Zhou F. Q. Snider W. D. (2005) Cell biology. GSK-3beta and microtubule assembly in axons. Science 308, 211 214.
49. Zhou F. Q., Zhou J., Dedhar S., Wu Y. H. Snider W. D. (2004) NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42, 897 912.
50. Zhou Y., Bhatia I., Cai Z., He Q. Y., Cheung P. T. Chiu J. F. (2008) Proteomic analysis of neonatal mouse brain: evidence for hypoxia- and ischemia-induced dephosphorylation of collapsin response mediator proteins. J. Proteome Res. 7, 2507 2515.